California Life Sciences Association
Aug 19, 2016
Business Cocktail
Zymeworks licenses new drug discovery platform from Innovative Targeting Solutions Zymeworks, a biotech company working on bispecific antibodies, has signed a licensing deal with Innovative Targeting Solutions (ITS) for HuTARG, which works as a protein engineering platform, and is the first fully mammalian tech that...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
